Amanda L. Muehlbauer

Amanda L. Muehlbauer

Auto-generated profile, based on publicly available information

Amanda L. Muehlbauer

Department of Ecology, Evolution, and Behavior, University of Minnesota, Minneapolis, MN, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2022 in Science
Verified
Journal Article
Closed access
TSTaichi A Suzuki
Taichi A Suzuki
JFJ. Liam Fitzstevens
J. Liam Fitzstevens
VSVictor T. Schmidt
Victor T. Schmidt
HEHagay Enav
Hagay Enav
KHKelsey E. Huus
Kelsey E. Huus
RLRuth E. Ley
Ruth E. Ley
The gut microbiomes of human populations worldwide have many core microbial species in common. However, within a species, some strains can show remarkable population specificity. The question is whether such specificity arises from a shared evolutionary history (codiversification) between humans and their microbes. To test for codiversification of host and microbiota, we analyzed paired gut metagenomes and human genomes for 1225 individuals in Europe, Asia, and Africa, including mothers and their children. Between and within countries, a parallel evolutionary history was evident for humans and their gut microbes. Moreover, species displaying the strongest codiversification independently evolved traits characteristic of host dependency, including reduced genomes and oxygen and temperature sensitivity. These findings all point to the importance of understanding the potential role of population-specific microbial strains in microbiome-mediated disease phenotypes.

1 November 2021 in Cell Reports
Verified
Journal Article
Open access
AMAmanda L. Muehlbauer
Amanda L. Muehlbauer
ARAllison L. Richards
Allison L. Richards
AAAdnan Alazizi
Adnan Alazizi
MBMichael B. Burns
Michael B. Burns
Andres M. GomezAndres M. Gomez
Andres M. Gomez
RBRan Blekhman
Ran Blekhman
The gut microbiome exhibits extreme compositional variation between hominid hosts. However, it is unclear how this variation impacts host physiology across species and whether this effect can be mediated through microbial regulation of host gene expression in interacting epithelial cells. Here, we characterize the transcriptional response of human colonic epithelial cells in vitro to live microbial communities extracted from humans, chimpanzees, gorillas, and orangutans. We find that most host genes exhibit a conserved response, whereby they respond similarly to the four hominid microbiomes. However, hundreds of host genes exhibit a divergent response, whereby they respond only to microbiomes from specific host species. Such genes are associated with intestinal diseases in humans, including inflammatory bowel disease and Crohn’s disease. Last, we find that inflammation-associated microbial species regulate the expression of host genes previously associated with inflammatory bowel disease, suggesting health-related consequences for species-specific host-microbiome interactions across hominids.

28 January 2026 in bioRxiv
Verified
Preprint
Open access
KLKatja Della Libera
Katja Della Libera
EAElizabeth M. Adamowicz
Elizabeth M. Adamowicz
AMAmanda Muehlbauer
Amanda Muehlbauer
SPSambhawa Priya
Sambhawa Priya
AAAdnan Alazizi
Adnan Alazizi
RBRan Blekhman
Ran Blekhman
Colorectal cancer (CRC) is associated with changes in the microbial communities in the tumor microenvironment. Although metabolic reprogramming is an important feature of host cells in CRC, little is known about metabolic changes in the tumor-associated microbiota and how these microbial metabolic alterations can contribute to disease. Here, we investigated metabolic host-microbiome interactions in CRC using complementary computational and experimental approaches. Using patient-specific in silico metabolic models across three independent datasets, we discovered that Fusobacterium , a cancer-promoting taxon, consistently grows faster in tumor-associated versus normal tissue-associated microbiomes. This finding prompted us to investigate whether host metabolic changes drive these microbial growth advantages. By integrating our metabolic predictions with host transcriptomics data, we identified correlations between tumor gene expression and the growth of CRC-associated taxa (including Porphyromonadaceae , Blautia , and Streptococcus ), as well as associations between host genes and microbial metabolism of dietary components (including choline, amino acids, and starch). To test whether these correlations reflect causal relationships, we simulated spent medium experiments in silico , demonstrating that Blautia preferentially grows on metabolites produced by tumor versus normal host cells. We further validated the direct impact of microbes on host metabolism using an in vitro system, where colon cancer cells exposed to human microbiomes showed gene expression changes in response to specific taxa including Bilophila , Anaerotruncus , and Escherichia . Together, these findings reveal a metabolic dialogue between host and microbiome in CRC, where tumor metabolic reprogramming creates a favorable environment for pathogenic microbes, which in turn may reinforce tumorigenic processes through metabolic crosstalk.